Dr. Reddy's Laboratories Recalled Succinylcholine Injection Over Safety Concerns
Dr. Reddy's Laboratories recalled 571 vials of Succinylcholine Chloride Injection on September 26, 2025. The recall stems from out-of-specification results during stability testing, indicating a decreased preservative concentration. The product is used for intravenous or intramuscular administration and is available by prescription only.
Product Details
The recalled product is Succinylcholine Chloride Injection, USP, 200 mg/10 mL, distributed in 25 x 10 mL multiple-dose vials. The NDC number is 43598-666-25. This product was distributed nationwide.
The Hazard
The recall is due to out-of-specification results during six-month stability testing. The decreased preservative concentration raises concerns about the product's safety and efficacy.
Reported Incidents
No specific incidents or injuries have been reported related to this recall. The high hazard classification indicates potential serious risks.
What to Do
Stop using the product immediately. Contact Dr. Reddy's Laboratories or your healthcare provider for further guidance.
Contact Information
For more information, call Dr. Reddy's Laboratories at their customer service line or visit their official website.